Boston Scientific’s vice president and general manager Ken Spears shares his thoughts about the potential for Canada to become an early adopter of innovation and to move towards an outcome-based healthcare model and the medtech solutions Boston Scientific is introducing in the Canadian market.
You are yourself a vocal advocate for outcome-based healthcare models. How do you assess the willingness to implement these models in Canada?
"There are jurisdictions where the government has acknowledged its role in enabling innovation adoption and they have done a great job of coordinating the actions of multiple organizations in the same pursuit."
